综合泛癌分析和乳腺癌验证确定BEND3作为潜在的预后和免疫生物标志物

Yuting Gou1, Yongxiang Li1, Yiyang Wang1

  • 1Department of Breast Surgery, Center of Digestive and Vascular, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.

概括

这项研究表明,BEND3在许多癌症中过度表达,并与预后不佳有关. BEND3促进癌细胞的增殖和入侵,表明其作为预后生物标志物的潜力.